Exploring the role of liver resection as a first-line treatment option for multinodular BCLC-A hepatocellular carcinoma

Journal of Liver Cancer · Published 2024-08-19 · DOI 10.17998/jlc.2024.08.08

Authors being retrieved — see the publisher record. https://doi.org/10.17998/jlc.2024.08.08

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year

2024

Related articles

• Alcohol-related hepatocellular carcinoma: surveillance and primary prevention · Journal of Liver Cancer · 2026 · Same journal
• Impact of the 2024 medical-policy conflict on hepatocellular carcinoma management in Korea · Journal of Liver Cancer · 2025 · Same journal
• Congratulatory remarks · Journal of Liver Cancer · 2025 · Same journal
• Enhanced radiofrequency ablation for recurrent hepatocellular carcinoma post-transarterial chemoembolization: a prospective study utilizing twin internally cooled-perfusion electrodes · Journal of Liver Cancer · 2025 · Same journal
• Contemporary overview of liver transplantation for intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma · Journal of Liver Cancer · 2026 · Same journal
• Hepatocellular carcinoma in Korea: an analysis of the 2016-2018 Korean Nationwide Cancer Registry · Journal of Liver Cancer · 2025 · Same journal
• Second-line antidiabetic drugs: friend or foe of the liver · Journal of Liver Cancer · 2025 · Same journal
• Expert survey on systemic therapy indications for hepatocellular carcinoma in Korea: bridging clinical practice and reimbursement criteria · Journal of Liver Cancer · 2025 · Same journal
• Cure can be achieved by conversion to microwave ablation following atezolizumab-bevacizumab therapy in unresectable hepatocellular carcinoma · Journal of Liver Cancer · 2024 · Same journal
• Advancing Korean nationwide registry for hepatocellular carcinoma: a systematic sampling approach utilizing the Korea Central Cancer Registry database · Journal of Liver Cancer · 2024 · Same journal